With a growing debate around the British Journal of Psychiatry’s decision not to retract a controversial abortion paper, we invite you to delve deeper into the ensuing implications for scientific publication standards and the interplay between science, politics, and law.

Discover the pioneering research connecting marijuana use with modifications in the human epigenome. The study brings to light potential health implications and illuminates areas for future exploration.

AMA’s introduction of a CPT III code for psychedelic therapies denotes a potential paradigm shift in the treatment of mental health conditions, inviting clinicians to explore these emerging modalities.

This groundbreaking study from Northwestern Medicine unveils a surprising interaction of antipsychotic drugs with neurons, prompting a revision of our understanding of psychosis treatment and opening new pathways for more effective, safer drugs.

A phase 3 clinical trial of solanezumab, an antibody that targets monomeric amyloid, showed no significant slowing of cognitive decline in patients with preclinical Alzheimer’s disease over 240 weeks, despite decreased brain amyloid levels.

Exploring new avenues for treating depression in youth, this compelling research showcases the potential of physical activity interventions in significantly reducing depressive symptoms, particularly among those aged 13 years and above. Find out how this accessible, non-pharmacological approach could transform pediatric mental health care.